The role of radiotherapy in the management of resected uterine papillary serous and clear cell carcinoma

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 141, Issue 2, 2008, Pages 163-168

  Batchelor, Emma C ^a   Watkins, John M ^a   Creasman, William T ^a   Kohler, Matthew F ^a   Sinha, Debajyoti ^b   Jenrette, Joseph M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Adjuvant therapy; Clear cell carcinoma; Radiotherapy; Serous carcinoma; Uterine neoplasms

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; PACLITAXEL;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMBINATION CHEMOTHERAPY; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PAPILLARY CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UTERUS CARCINOMA; UTERUS PAPILLARY SEROUS CARCINOMA;

EID: 56249091725     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2008.07.019     Document Type: Article

References (30)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics. CA Cancer J Clin 57 (2007) 43-66
2. Wilson T.O., Podratz K.C., Gaffey T.A., et al. Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma. Am J Obstet Gynecol 162 (1990) 418-423
3. Faratian D., Stillie A., Busby-Earle R.M., et al. A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome. Int J Gynecol Cancer 16 (2006) 972-978
4. Mehta N., Yamada S.D., Rotmensch J., et al. Outcome and pattern of failure in pathologic stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 57 (2003) 1004-1009
5. Murphy K.T., Rotmensch J., Yamada S.D., et al. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 55 (2003) 1272-1276
6. Rosenberg P., Blom R., Hogberg T., et al. Death rate and recurrence pattern among 841 clinical stage I endometrial cancer patients with special reference to uterine papillary serous carcinoma. Gynecol Oncol 51 (1993) 311-315
7. Christopherson W.M., Alberhaskey R.C., and Connely P.J. Carcinoma of the endometrium: I. a clinicopathologic study of clear cell carcinoma and secretory carcinoma. Cancer 49 (1982) 1511-1514
8. Albeler V.M., and Kjorstad K.E. Clear cell carcinoma of the endometrium: a histopathological and clinical study of 97 cases. Gynecol Oncol 40 (1991) 207-217
9. Carcangiu M.L., and Chambers J.T. Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival. Int J Gynecol Pathol 14 (1995) 30-38
10. Abeler V.M., Vergote I.B., Kjorstad K.E., et al. Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern. Cancer 78 (1996) 1740-1747
11. Morrow C.P., Bundy B.N., Kurman R.J., et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40 (1991) 55-65
12. Sall S., Sonnenblick B., and Stone M.L. Factors affecting survival of patients with endometrial adenocarcinoma. Am J Obstet Gynecol 107 (1970) 116-123
13. NCCN.org. 1 May 2008. NCCN Practice Guidelines in Oncology; 14 April 2008. .
14. Lim P., Al Kushi A., Gilks B., et al. Early stage uterine papillary serous carcinoma of the endometrium: effect of adjuvant whole abdominal radiotherapy and pathologic parameters on outcome. Cancer 91 (2001) 752-757
15. Piura B., Meirovitz M., Shulman M., et al. Uterine papillary serous carcinoma: study of 19 cases. Eur J Obstet Gynecol Reprod Bio 79 (1998) 69-73
16. Cirisano Jr. F.D., Robboy S.J., Dodge R.K., et al. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Gynecol Oncol 77 (2000) 55-65
17. Tay E.H., and Ward B.G. The treatment of uterine papillary serous carcinoma: are we doing the right thing?. Int J Gynecol Cancer 9 (1999) 463-469
18. Bristow R.E., Asrari F., Trimble E.L., et al. Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (stage I-II) disease. Gynecol Oncol 81 (2001) 279-286
19. 192 Ir) and chemotherapy. Int J Radiat Oncol Biol Phys 40 (1998) 77-84
20. Grice J., Ek M., Greer B., et al. Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients. Gynecol Oncol 69 (1998) 69-73
21. Carcangiu M.L., and Chambers J.T. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma. Gynecol Oncol 47 (1992) 298-305
22. Nguyen N.P., Sallah S., Karlsson U., et al. Prognosis for papillary serous carcinoma of the endometrium after surgical staging. Int J Gynecol Cancer 11 (2001) 305-311
23. Gehrig P.A., Groben P.A., Fowler W.C., et al. Noninvasive papillary serous carcinoma of the endometrium. Obstet Gynecol 97 (2001) 153-157
24. Kelly M., O'Mally D.M., and Hui P. Improved survival in surgical stage I patients with uterine papillary serous carcinomas (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol 98 (2005) 353-359
25. Rosenberg P., Boeryd B., and Simonsen E. A new aggressive treatment approach to high-grade endometrial cancer of possible benefit to patients with stage I uterine papillary cancer. Gynecol Oncol 48 (1993) 32-37
26. Hamilton C.A., Kapp D.S., and Chan J.K. Clinical aspects of uterine papillary serous carcinoma. Curr Opin Obstet Gynecol 20 (2008) 26-33
27. Randall M.E., Filiaci V.L., Muss H., et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 24 (2006) 36-44
28. Fleming G.F., Brunetto V.L., Cella D., et al. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus figrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 22 (2004) 2159-2166
29. Hamilton C.A., Cheung M.K., Osann K., et al. The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma. Gynecol Oncol 103 (2006) 679-683
30. Vaidya A.P., Littell R., Krasner C., and Duska L.R. Treatment of uterine papillary serous carcinoma with platinum-based chemotherapy and paclitaxel. Int J of Gynecol Cancer 16 (2006) 267-272